IVF Lab Automation
Transforming IVF through automation.
The mission of AutoIVF is to transform In Vitro Fertilization (IVF) by automating central IVF procedures that are costly and time-consuming. Automation will result in increased reliability, reduced cost, and increased accessibility of IVF to all infertility patients. This is achieved through the development of high-throughput microfluidic technologies specifically targeted at selected components of the IVF procedure.
Thomas L. Toth MD.,
Chief Executive Officer
Founding Director of Massachusetts General Hospital – IVF Department;
Reproductive endocrinologist, Boston IVF; Associate Professor, Harvard Medical School.
Mehmet Toner, Ph.D., Technology Advisor
Professor of Biomedical Engineering, Massachusetts General Hospital, Harvard Medical School, and Harvard-MIT Health Sciences & Technology.
Ravi Kapur, Ph.D., Technology Advisor
Chief Executive Officer of BendBio Inc.
Scientist, engineer, and entrepreneur with 30 years of experience in technology commercialization.
Emre Ozkumur Ph.D.,
Vice President of R&D
VP of Research and Development at AutoIVF. Innovation expert with 15 years of technology development experience in biotech/medtech.
Mitchel Sayare Ph.D., Business Advisor
Chairman, Altimmune, Inc. (NASDAQ:ALT);
Director, Energesis, Inc.; Director, Advanced Aesthetic Technologies, Inc.; Chairman, Barrow Neurological Foundation.
Alan Penzias, MD
Reproductive endocrinologist, Boston IVF; Associate Professor, Harvard Medical School
Michael Alper MD, Clinical Advisor
Co-founder, Medical Director and President of Boston IVF; Associate Clinical Professor, Harvard Medical School
Denny Sakkas Ph.D., Embryology Advisor
Chief Scientific Officer, Boston IVF;
Associate Professor, Yale University School of Medicine; Chief Scientific Officer, Molecular Biometrics.
AutoIVF Inc. Facilities
200 Dexter Avenue Suite 120, Watertown, MA 02461